Почетна › Колоректални карцином › Florida › Orlando
Kliničke studije za Колоректални карцином u gradu Orlando, FL
Jedna studija za Колоректални карцином traži učesnike na lokaciji u gradu Orlando ili u blizini. Otvorite je da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Initial Safety of SFM Plus OTOLoc for Creating Side-to-side or End-to-side Colorectal Anastomoses
Тражи се учесник
- Orlando Health, Orlando
Zanzalintinib Alone or in Combination With Pembrolizumab and Berahyaluronidase Alfa in Participants With Colorectal Cancer With Molecular Residual Disease
Тражи се учесникФаза 3
- Orlando Health Cancer Institute, Orlando
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Тражи се учесникФаза 1
- AdventHealth Celebration, Celebration · 17 ми удаљено
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Тражи се учесникФаза 3
- Clinical Study Site, Orlando
- Clinical Study Site, Orlando
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Тражи се учесникФаза 3
- AdventHealth Medical Group Oncology and Hematology at Orlando, Orlando
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Тражи се учесникФаза 3
- AdventHealth Cancer Institute, Orlando
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- Sarah Cannon Research Institute (Lake Nona), Orlando
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Тражи се учесникФаза 3
- Advent Health, Orlando
- Orlando Health Cancer Institute Downtown Orlando, Orlando
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
Тражи се учесникФаза 2
- AdventHealth Orlando /ID# 270789, Orlando
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Тражи се учесникФаза 1
- Research Site, Orlando
Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic
Тражи се учесникФаза 1
- SCRI at Florida Cancer Specialists, Orlando
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
Тражи се учесникФаза 2
- Orlando Health Cancer Institute, Orlando
A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
Тражи се учесникФаза 1/2
- Florida Cancer Specialists, Orlando
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
Тражи се учесникФаза 1
- AdventHealth Celebration, Celebration · 17 ми удаљено
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Тражи се учесникФаза 1/2
- Advent Health, Orlando
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Тражи се учесникФаза 1
- Exelixis Clinical Site #48, Celebration · 17 ми удаљено
A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1
- GSK Investigational Site, Reunion · 23 ми удаљено
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- AdventHealth Celebration, Celebration · 17 ми удаљено
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Тражи се учесникФаза 1
- Florida Cancer Specialists, Orlando
- Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando
A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
Тражи се учесникФаза 2
- Advent Health, Orlando
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1/2
- Florida Cancer Specialists-Lake Nona, Orlando
Studije za Колоректални карцином u drugim gradovima
- Houston, TX101 студија
- New York City, NY86 студија
- Nashville, TN67 студија
- Boston, MA62 студија
- Los Angeles, CA61 студија
- Arlington, VA54 студија
- St. Louis, MO51 студија
- San Antonio, TX43 студија
- Philadelphia, PA41 студија
- Grand Rapids, MI40 студија
- Baldwin Park, CA37 студија
- Tampa, FL36 студија
Ostale studije u gradu Orlando
- Немалоклетни карцином плућа47 студија
- Гојазност33 студија
- Алцхајмерова болест29 студија
- Метастатски карцином28 студија
- Гојазност27 студија
- Dijabetes tipa 225 студија
- Рак јајника24 студија
- Рак (све врсте)24 студија
- Рак дојке23 студија
- Рак плућа23 студија
- Ulcerativni kolitis21 студија
- Плоскоклеточни карцином главе и врата21 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.